Breaking News

AGC Biologics Seattle Site Receives Anvisa GMP Certification

Authorization clears the way for customers to enter Brazil’s $40 billion pharmaceutical market.

Author Image

By: Charlie Sternberg

Associate Editor

AGC Biologics’ Seattle manufacturing facility has received Good Manufacturing Practices (GMP) certification from Brazil’s health regulatory authority, Agência Nacional de Vigilância Sanitária (Anvisa). The certification allows biologics and biosimilars manufactured at the site to be commercialized in Brazil, the largest pharmaceutical market in South America. “This certification ensures that our customers are able to deliver product to patients in need of treatment in the Brazilian market,” s...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters